.jpg)
Key Features:
- Fully aligned with the NMC CBME Curriculum 2024, with learning objectives in every chapter and integrated pharmacology-related AETCOM modules.
- 118 cases for case-based learning, with clinical insight boxes linking core concepts to clinical application.
- Evidence-based pharmacotherapy supported by WHO, ACC/AHA, ISH, NICE, SIGN and GINA recommendations, meta-analyses and landmark clinical trials.
- Latest drugs and therapeutic advances, including GLP-1 receptor agonists, SGLT-2 inhibitors, neprilysin inhibitors, orexin antagonists, PCSK9 inhibitors and CGRP antagonists.
- Updated treatment algorithms for diabetes, hypertension, heart failure, tuberculosis, cardiac arrest, infertility, peripheral vascular disease and asthma.
- Current National Health Programme guidelines for tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis and viral hepatitis.
- Expanded antimicrobial stewardship content including the WHO AWaRe classification of antibiotics.
- Dedicated coverage of the Pharmacovigilance Programme of India, drug safety monitoring and rational therapeutic practice.
- Student-friendly presentation with revised tables, flowcharts, line diagrams and boxes, and important abbreviations compiled in one section.
- ConceptRx digital companion providing exam-ready smart notes, chapter summaries, mind maps, university PYQs and high-yield questions.
- Organised into 14 Sections spanning 70 chapters across 1,064 pages.
